Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 1
1996 1
1997 1
1999 2
2000 4
2002 1
2003 3
2004 4
2005 2
2006 3
2007 5
2008 10
2009 8
2010 9
2011 8
2012 12
2013 15
2014 7
2015 8
2016 1
2017 9
2018 11
2019 5
2020 3
2021 9
2022 6
2023 11
2024 10
2025 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

155 results

Results by year

Filters applied: . Clear all
Page 1
Prednisone vs high-dose dexamethasone in newly diagnosed adult primary immune thrombocytopenia: a randomized trial.
Mazzucconi MG, Rodeghiero F, Avvisati G, De Stefano V, Gugliotta L, Ruggeri M, Vianelli N, Fazi P, Paoloni F, Sargentini V, Baldacci E, Ferretti A, Martino B, Vincelli ID, Carli G, Fortuna S, Di Ianni M, Ranalli P, Palandri F, Polverelli N, Lugli E, Rivolti E, Patriarca A, Rago A, D'Adda M, Gentile M, Siragusa S, Sibilla S, Carella AM, Rossi E, Battistini R, Zaja F, Bocchia M, Di Renzo N, Musto P, Crugnola M, Giuffrida AC, Krampera M, Tafuri A, Santoro C. Mazzucconi MG, et al. Among authors: di ianni m. Blood Adv. 2024 Mar 26;8(6):1529-1540. doi: 10.1182/bloodadvances.2023010975. Blood Adv. 2024. PMID: 38231017 Free PMC article. Clinical Trial.
Long-term pharmacodynamic and clinical effects of twice- versus once-daily low-dose aspirin in essential thrombocythemia: The ARES trial.
Rocca B, Tosetto A, Petrucci G, Rossi E, Betti S, Soldati D, Iurlo A, Cattaneo D, Bucelli C, Dragani A, Di Ianni M, Ranalli P, Palandri F, Vianelli N, Beggiato E, Lanzarone G, Ruggeri M, Carli G, Elli EM, Renso R, Randi ML, Bertozzi I, Loscocco GG, Ricco A, Specchia G, Vannucchi AM, Rodeghiero F, De Stefano V, Patrono C; Aspirin Regimens in EsSential thrombocythemia (ARES) Investigators. Rocca B, et al. Among authors: di ianni m. Am J Hematol. 2024 Aug;99(8):1462-1474. doi: 10.1002/ajh.27418. Epub 2024 Jun 15. Am J Hematol. 2024. PMID: 38877813 Free article. Clinical Trial.
NOTCH and Graft-Versus-Host Disease.
Di Ianni M, Del Papa B, Baldoni S, Di Tommaso A, Fabi B, Rosati E, Natale A, Santarone S, Olioso P, Papalinetti G, Giancola R, Accorsi P, Di Bartolomeo P, Sportoletti P, Falzetti F. Di Ianni M, et al. Front Immunol. 2018 Aug 10;9:1825. doi: 10.3389/fimmu.2018.01825. eCollection 2018. Front Immunol. 2018. PMID: 30147692 Free PMC article. Review.
NOTCH1 Aberrations in Chronic Lymphocytic Leukemia.
Rosati E, Baldoni S, De Falco F, Del Papa B, Dorillo E, Rompietti C, Albi E, Falzetti F, Di Ianni M, Sportoletti P. Rosati E, et al. Among authors: di ianni m. Front Oncol. 2018 Jun 27;8:229. doi: 10.3389/fonc.2018.00229. eCollection 2018. Front Oncol. 2018. PMID: 29998084 Free PMC article. Review.
CD19.CAR T-cell-derived extracellular vesicles express CAR and kill leukemic cells, contributing to antineoplastic therapy.
Lanuti P, Guardalupi F, Corradi G, Florio R, Brocco D, Veschi S, Pennese E, De Bellis D, D'Ascanio F, Piro A, De Lellis L, Simeone P, Cufaro MC, Pilato S, D'Amario I, Villanova I, Di Francesco B, Di Re L, Verginelli F, Pieragostino D, Salutari P, Colasante F, Natale A, Mattoli MV, Vespa S, Fontana A, Giancola R, Fabi B, Baldoni S, Santarone S, Restuccia F, Tinari N, Del Boccio P, Cama A, Di Ianni M. Lanuti P, et al. Among authors: di ianni m. Blood Adv. 2025 Jun 24;9(12):2907-2919. doi: 10.1182/bloodadvances.2024014860. Blood Adv. 2025. PMID: 39903124 Free PMC article.
Dosing and clinical outcomes of ruxolitinib in patients with myelofibrosis in a real-world setting: Interim results of the Italian observational study (ROMEI).
Breccia M, Palandri F, Martelli M, Mendicino F, Malato A, Palumbo GA, Sibilla S, Di Renzo N, Abruzzese E, Siragusa S, Crugnola M, Selleri C, Pane F, Sportoletti P, Martino B, Impera S, Ricco A, Langella M, Ditonno P, Carli G, Itri F, Liberati AM, Urbano T, Tafuri A, Polizzi V, Pastore D, Morsia E, Benevolo G, Micucci G, Farina G, Bonifacio M, Elli EM, Gardellini A, De Stefano V, Caocci G, Falcone AP, Vallisa D, Brociner M, Tiribelli M, Binotto G, Pocali B, Cavazzini F, Tomassetti S, Lunghi F, Di Ianni M, Allegra A, Anaclerio B, Mazzotta S, Orofino N, Gherlinzoni F, Castiglioni C, Landoni M, Valsecchi D, Magnoli M, Guglielmelli P, Passamonti F. Breccia M, et al. Among authors: di ianni m. Cancer. 2025 Apr 1;131(7):e35801. doi: 10.1002/cncr.35801. Cancer. 2025. PMID: 40111826 Free PMC article.
18F-Fluorodeoxyglucose Uptake in PDGFRA-Mutant Gastrointestinal Stromal Tumors.
Nigro MC, Marchetti A, Fumagalli ER, De Luca I, Bertuzzi AF, Grimaudo MS, Grignani G, D'Ambrosio L, Merlini A, Badalamenti G, Incorvaia L, Dimino A, Gasperoni S, Vincenzi B, Fanti S, Di Federico A, Campana D, Pantaleo MA, Nannini M; Tumori Rari Bologna. Nigro MC, et al. JAMA Netw Open. 2025 Jan 2;8(1):e2456058. doi: 10.1001/jamanetworkopen.2024.56058. JAMA Netw Open. 2025. PMID: 39853981 Free PMC article.
155 results